PetVivo to showcase equine treatments at TEVA symposium in Texas

PetVivo Holdings plans to exhibit at the Texas Equine Veterinary Association’s 2026 Summer CE Symposium in Horseshoe Bay, Texas, from July 30 to Aug. 1. The company will highlight SPRYNG with OsteoCushion Technology and PrecisePRP as it looks to broaden awareness among equine veterinarians.

Why it matters: - PetVivo is targeting equine veterinarians at a major continuing-education event. - The exhibition gives the company a direct forum to promote its veterinary medical devices for joint and soft tissue conditions. - The company is using the symposium to build awareness of regenerative treatment options for horses.

What happened: - PetVivo Holdings announced it will exhibit at the Texas Equine Veterinary Association 2026 Summer CE Symposium. - The event runs July 30-Aug. 1, 2026, at Horseshoe Bay Resort in Horseshoe Bay, Texas. - PetVivo will be at booth/table 78. - Exhibition hours are Thursday, July 30 from 2:30 p.m. to 8:00 p.m., Friday, July 31 from 10:00 a.m. to 4:00 p.m., and Saturday, Aug. 1 from 10:00 a.m. to 1:30 p.m.

The details: - PetVivo plans to feature SPRYNG with OsteoCushion Technology, an intra-articular injectable veterinary medical device. - SPRYNG contains sterilized extracellular matrix microparticles. - After injection, the microparticles adsorb to the synovial lining and integrate with subsynovial tissue. - The product is designed to support normal joint mechanics. - SPRYNG is intended to help manage noninfectious sources of joint pain, including osteoarthritis, degenerative joint disease and joint instability. - PetVivo also plans to discuss PrecisePRP, another product in its veterinary lineup. - John Lai, PetVivo’s CEO, said the symposium offers an opportunity to show how SPRYNG and PrecisePRP are helping veterinarians address orthopedic and soft tissue conditions. - Lai said the company will also discuss the clinical evidence supporting its products and expand awareness of regenerative solutions for horses. - PetVivo says it can be contacted at info1@petvivo.com. - The company’s websites are PetVivo Holdings, PetVivo Animal Health and SPRYNG Health.

Between the lines: - The symposium appearance puts PetVivo in front of a niche, high-value professional audience that can influence product adoption. - The company is positioning its products around regenerative medicine, a category that continues to gain attention in veterinary care. - PetVivo is also leaning on clinical evidence and event visibility rather than a broad consumer campaign.

What's next: - PetVivo will present its products during the three-day symposium window. - The company is likely to use the event to generate veterinary interest and follow-up conversations after the conference. - PetVivo’s broader commercial push continues around SPRYNG and PrecisePRP, which are already available for sale.